Actively Recruiting
Mobile Lung Cancer Screening
Led by Hospices Civils de Lyon · Updated on 2025-09-09
4312
Participants Needed
2
Research Sites
168 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Lung cancer screening using low-dose CT (LDCT) has been shown to reduce mortality in high-risk populations. In 2022, the French National Cancer Institute (INCa) issued guidelines recommending screening for individuals aged 50-74 with a history of heavy smoking, including current smokers or those who quit less than 15 years ago. A national pilot program (IMPULSION) will be launched in 2025. Lung cancer incidence is strongly correlated with socioeconomic status, yet underserved populations remain difficult to engage in screening programs. Mobile health units using a "reach-out" strategy have demonstrated effectiveness in other countries (UK, Brazil, USA). In France, this approach has been used for breast cancer screening via mobile mammography units. The MobILYAD project aims to compare two screening modalities- a mobile demedicalized unit (CT-equipped van with trained nurses) and a conventional hospital-based unit- to assess the effectiveness of mobile screening in reaching socially disadvantaged populations.
CONDITIONS
Official Title
Mobile Lung Cancer Screening
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 50 and 74 years
- Current smokers or former smokers who quit less than 15 years ago
- Smoking history of 20 pack-years or more, or equivalent tobacco use accounting for duration and quantity
- Affiliated with social security
- Signed informed consent after receiving full study information including risks
You will not qualify if you...
- Severe health conditions that prevent lung cancer tests or treatment such as surgery or radiotherapy
- Impaired general condition with performance status 2 or higher
- Shortness of breath at rest (mMRC grade 4)
- History of cancer currently monitored by chest CT or PET scans
- Personal history of lung cancer
- Symptoms suggesting lung cancer like hemoptysis, unexplained weight loss, or recent respiratory changes
- Refusal to participate or withdrawal of consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
" Centre de dépistage mobile " - Hôpital Lyon Sud
Pierre-Bénite, France, 69310
Actively Recruiting
2
Service de Pneumologie " Centre de dépistage non mobile " - Hôpital Lyon Sud
Pierre-Bénite, France, 69310
Actively Recruiting
Research Team
S
Sébastien COURAUD, Pr
CONTACT
J
Julie DE-BELMONT
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here